WallStreetZenWallStreetZen

NASDAQ: GOSS
Gossamer Bio Inc Earnings & Revenue

GOSS earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$172.6M
Current Profit Margin
0%

GOSS Return on Equity

Current Company
-525.7%
Current Industry
16.7%
Current Market
28.2%
GOSS's Return on Equity (-525.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GOSS announces earnings.

GOSS Return on Assets

Current Company
-62.7%
Current Industry
3.2%
GOSS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GOSS Return on Capital Employed

Current Company
-71.32%
Current Industry
-43.6%
GOSS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GOSS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GOSS$0.00-$155.21M-$172.58MN/AN/A
CGENN/AN/AN/AN/AN/A
SGMT$2.00M-$27.78M-$27.92MN/AN/A
XFOR$0.00-$120.35M-$128.91M-100.00%N/A
CRDF$610.00k-$39.82M-$40.25M+12.39%N/A

Gossamer Bio Earnings & Revenue FAQ

What were GOSS's earnings last quarter?

On Invalid Date, Gossamer Bio (NASDAQ: GOSS) reported Q1 2024 earnings per share (EPS) of -$0.19, up 63.46% year over year. Total Gossamer Bio earnings for the quarter were -$41.93 million. In the same quarter last year, Gossamer Bio's earnings per share (EPS) was -$0.52.

If you're new to stock investing, here's how to buy Gossamer Bio stock.

What was GOSS's earnings growth in the past year?

As of Q2 2024, Gossamer Bio's earnings has grown year over year. Gossamer Bio's earnings in the past year totalled -$172.58 million.

What was GOSS's revenue last quarter?

On Invalid Date, Gossamer Bio (NASDAQ: GOSS) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Gossamer Bio's revenue was $0.00.

What was GOSS's revenue growth in the past year?

As of Q2 2024, Gossamer Bio's revenue has grown null year over year. Gossamer Bio's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.